PyInvesting

Market research

49Z.F Cellink AB (publ)

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
122M
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
2.54

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Cellink AB (publ) is currently in a long term uptrend where the price is trading 30.4% above its 200 day moving average.

From a valuation standpoint, the stock is 92.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 96.0.

Based on the above factors, Cellink AB (publ) gets an overall score of 2/5.